產品櫥窗
-
Remdesivir, >98%
|
產品型號：101-1809249-37-3 商品規格： |
 |
Remdesivir,a monophosphoramidate prodrug of an adenosine analog, is an investigational broad-spectrum antiviral agent with in vitro activity against multiple RNA viruses, including Ebola and CoV. Synonym: GS-5734
C27H35N6O8P
M.W.: 602.58
M.W.: 602.58
Remdesivir, or GS-5734, is an adenosine triphosphate analog first described in the literature in 2016 as a potential treatment for Ebola. In 2017, its activity against the coronavirus family of viruses was also demonstrated. Remdesivir is also being researched as a potential treatment to SARS-CoV-2, the coronavirus responsible for COVID-19. Remdesivir was granted an FDA Emergency Use Authorization on 1 May 2020. This is not the same as an FDA approval.
Warren TK, et al. Nature. 2016 17;531(7594):381-5.
Warren TK, et al. Nature. 2016 17;531(7594):381-5.
Agostini ML, et al. mBio. 2018 6;9(2).
Store at -20℃
Shipping at Room Temp within Taiwan; may vary elsewhere
Shipping at Room Temp within Taiwan; may vary elsewhere